4.6 Article

Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis Analysis From the International Collaboration on Endocarditis-Prospective Echo Cohort Study

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCIMAGING.114.003397

关键词

echocardiography; endocarditis; odds ratio; risk factors; survival analysis

资金

  1. Fulbright scholarship
  2. Danish Heart Foundation
  3. National Institutes of Health [K24-AI093969, R01AI068804]
  4. [NIH-NIAID-RO1AI039108-16]

向作者/读者索取更多资源

Background-Staphylococcus aureus left-sided native valve infective endocarditis (LNVIE) has higher complication and mortality rates compared with endocarditis from other pathogens. Whether echocardiographic variables can predict prognosis in S aureus LNVIE is unknown. Methods and Results-Consecutive patients with LNVIE, enrolled between January 2000 and September 2006, in the International Collaboration on Endocarditis were identified. Subjects without S aureus IE were matched to those with S aureus IE by the propensity of having S aureus. Survival differences were determined using log-rank significance tests. Independent echocardiographic predictors of mortality were identified using Cox-proportional hazards models that included inverse probability of treatment weighting and surgery as a time-dependent covariate. Of 727 subjects with LNVIE and 1-year follow-up, 202 had S aureus IE. One-year survival rates were significantly lower for patients with S aureus IE overall (57% S aureus IE versus 80% non-S aureus IE; P<0.001) and in the propensity-matched cohort (59% S aureus IE versus 68% non-S aureus IE; P<0.05). Intracardiac abscess (hazard ratio, 2.93; 95% confidence interval, 1.52-5.40; P<0.001) and left ventricular ejection fraction <40% (odds ratio, 3.01; 95% confidence interval, 1.35-6.04; P=0.004) were the only independent echocardiographic predictors of in-hospital mortality in S aureus LNVIE. Valve perforation (hazard ratio, 2.16; 95% confidence interval, 1.21-3.68; P=0.006) and intracardiac abscess (hazard ratio, 2.25; 95% confidence interval, 1.26-3.78; P=0.004) were the only independent predictors of 1-year mortality. Conclusions-S aureus is an independent predictor of 1-year mortality in subjects with LNVIE. In S aureus LNVIE, intracardiac abscess and left ventricular ejection fraction <40% independently predicted in-hospital mortality and intracardiac abscess and valve perforation independently predicted 1-year mortality.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Temporal trends of mortality in patients with infective endocarditis: a nationwide study

Andreas Dalsgaard Jensen, Lauge Ostergaard, Jeppe Kofoed Petersen, Peter Laursen Graversen, Jawad Haider Butt, Katra Hadji-Turdeghal, Anders Dahl, Niels Eske Bruun, Kasper Iversen, Henning Bundgaard, Lars Kober, Emil Loldrup Fosbol

Summary: This nationwide study in Denmark observed improvements in both short- and long-term mortality rates among patients with first-time infective endocarditis between 1999 and 2018, suggesting advancements in patient care over time.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Pharmacology & Pharmacy

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

Amy Legg, Niamh Meagher, Sandra A. Johnson, Matthew A. Roberts, Alan Cass, Marc H. Scheetz, Jane Davies, Jason A. Roberts, Joshua S. Davis, Steven Y. C. Tong

Summary: The clinical risk factors for nephrotoxicity in Staphylococcus aureus bacteraemia are still unclear. In a clinical trial comparing standard therapy to combination therapy, it was found that the combination therapy group had a significantly higher incidence of acute kidney injury.

CLINICAL DRUG INVESTIGATION (2023)

Review Infectious Diseases

Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative review

Emily G. McDonald, Connor Prosty, Ryan Hanula, Emilie Bortolussi-Courval, Arthur M. Albuquerque, Steven Y. C. Tong, Fergus Hamilton, Todd C. Lee

Summary: This narrative review compares the strengths and limitations of observational study data with randomized controlled trial (RCT) data in evaluating antibiotic treatment durations. The findings indicate that, in terms of all-cause mortality at 30 days, RCT data provide some support for longer-course therapy, while observational study data show stronger support for longer-course therapy. Observational studies still face challenges in addressing potential sources of bias.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Correction Pharmacology & Pharmacy

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial (Oct, 10.1007/s40261-022-01204-z, 2022)

Amy Legg, Niamh Meagher, Sandra A. Johnson, Matthew A. Roberts, Alan Cass, Marc H. Scheetz, Jane Davies, Jason A. Roberts, Joshua S. Davis, Steven Y. C. Tong

CLINICAL DRUG INVESTIGATION (2023)

Article Medicine, General & Internal

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Alisa M. Higgins, Lindsay R. Berry, Elizabeth Lorenzi, Srinivas Murthy, Zoe McQuilten, Paul R. Mouncey, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Abi Beane, Wilma Van Bentum-Puijk, Zahra Bhimani, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Aiden Burrell, Adrian Buzgau, Meredith Buxton, Walton N. Charles, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Elizabeth O. Fagbodun, Mark Fitzgerald, Timothy D. Girard, Ewan C. Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, Christopher M. Horvat, David T. Huang, Nao Ichihara, Francois Lamontagne, John C. Marshall, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Bryan J. McVerry, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Karen Parry-Billings, Sam E. C. Peters, Luis F. Reyes, Kathryn M. Rowan, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Ary Serpa-Neto, Christopher W. Seymour, Manu Shankar-Hari, Lucy M. Stronach, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Lennie P. G. Derde, Anthony C. Gordon, Steve A. Webb, Patrick R. Lawler

Summary: The longer-term effects of therapies for critically ill COVID-19 patients are unknown. In this study, 4869 patients were randomized to receive different interventions, and it was found that treatment with IL-6 receptor antagonists and antiplatelet agents significantly improved survival rates after 180 days. These findings suggest that most therapies have consistent effects over a 6-month period.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Medicine, General & Internal

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19 A Randomized Clinical Trial

Patrick R. Lawler, Lennie P. G. Derde, Frank L. van de Veerdonk, Bryan J. McVerry, David T. Huang, Lindsay R. Berry, Elizabeth Lorenzi, Roland van Kimmenade, Frank Gommans, Muthiah Vaduganathan, David E. Leaf, Rebecca M. Baron, Edy Y. Kim, Claudia Frankfurter, Slava Epelman, Yvonne Kwan, Richard Grieve, Stephen O'Neill, Zia Sadique, Michael Puskarich, John C. Marshall, Alisa M. Higgins, Paul R. Mouncey, Kathryn M. Rowan, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Carly Au, Abi Beane, Wilma van Bentum-Puijk, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Aidan Burrell, Adrian Buzgau, Meredith Buxton, Maurizio Cecconi, Allen C. Cheng, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Justin Ezekowitz, Mark Fitzgerald, David Gattas, Lucas C. Godoy, Herman Goossens, Rashan Haniffa, David A. Harrison, Thomas Hills, Christopher M. Horvat, Nao Ichihara, Francois Lamontagne, Kelsey M. Linstrum, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Zoe McQuilten, Srinivas Murthy, Alistair D. Nichol, David R. J. Owen, Rachael L. Parke, Jane C. Parker, Katrina M. Pollock, Luis Felipe Reyes, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Christopher W. Seymour, Manu Shankar-Hari, Vanessa Singh, Alexis F. Turgeon, Anne M. Turner, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Scott Berry, Anthony C. Gordon, Colin J. McArthur, Steve A. Webb

Summary: In patients with COVID-19, overactivation of the renin-angiotensin system (RAS) may have negative clinical outcomes. This study aimed to determine if initiating angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) could improve outcomes in hospitalized COVID-19 patients. The results showed that in critically ill patients, the use of ACE inhibitors or ARBs did not improve, and likely worsened, clinical outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Infectious Diseases

A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus

Andrew Henderson, Matthew P. Cheng, Ka Lip Chew, Geoffrey W. Coombs, Joshua S. Davis, Jennifer M. Grant, Dan Gregson, Stefano G. Giulieri, Benjamin P. Howden, Todd C. Lee, Vi Nguyen, Jocelyn M. Mora, Susan C. Morpeth, James O. Robinson, Steven Y. C. Tong, Sebastiaan J. Van Hal

Summary: This study evaluated the performance of two antibiotic susceptibility testing methods (CLSI and EUCAST) in detecting blaZ-positive S. aureus strains. The results showed a lower VME rate for the EUCAST method compared to the CLSI method.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Multidisciplinary Sciences

Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA

Mark R. R. Davies, Nadia Keller, Stephan Brouwer, Magnus G. G. Jespersen, Amanda J. J. Cork, Andrew J. Hayes, Miranda E. E. Pitt, David M. P. De Oliveira, Nichaela Harbison-Price, Olivia M. M. Bertolla, Daniel G. G. Mediati, Bodie F. F. Curren, George Taiaroa, Jake A. A. Lacey, Helen V. V. Smith, Ning-Xia Fang, Lachlan J. M. Coin, Kerrie Stevens, Steven Y. C. Tong, Martina Sanderson-Smith, Jai J. J. Tree, Adam D. D. Irwin, Keith Grimwood, Benjamin P. P. Howden, Amy V. V. Jennison, Mark J. J. Walker

Summary: A new variant of Streptococcus pyogenes serotype M1 (M1(UK)) has been reported in the UK, which exhibits enhanced expression of the superantigen SpeA. A single SNP in the 5' leader sequence of ssrA is responsible for the upregulation of SpeA expression. This variant has also been observed in Australia and is associated with epidemic scarlet fever in Asia.

NATURE COMMUNICATIONS (2023)

Article Medicine, General & Internal

Epidemiology and Management of invasive infections among people who Use drugs (EMU): protocol for a prospective, multicentre cohort study

Lucy O. Attwood, Mellissa Bryant, Sue J. Lee, Olga Vujovic, Peter Higgs, Joseph S. Doyle, Andrew J. Stewardson

Summary: This study aims to describe the burden, clinical spectrum, management and outcomes of invasive infections in people who inject drugs (PWID), as well as determine the impact of current care models on treatment completion and post-discharge outcomes. It is a prospective multicentre cohort study conducted in Australian public hospitals, collecting data through medical records and patient interviews. Importance rating: 8/10.

BMJ OPEN (2023)

Review Medicine, General & Internal

Registry randomised trials: a methodological perspective

Dorota A. Doherty, Steven Y. C. Tong, Jennifer Reilly, Jane Shrapnel, Stephen McDonald, Susannah Ahern, Ian Harris, Charmaine S. Tam, Angela L. Brennan, Carol Hodgson, Leonie Wilcox, Anitha Balagurunathan, Belinda E. Butcher, Christopher M. Reid

Summary: Registry randomised clinical trials (RRCTs) can provide practical answers to clinical questions in a cost-effective way by embedding them into well-established registries. RRCTs can take different forms, such as parallel group trials, platform or adaptive trials, cluster randomised trials, and cluster randomised stepped-wedge trials. With advancements in data linkage and quality, RRCTs have the potential to play a significant role in addressing clinical questions pragmatically.

BMJ OPEN (2023)

Article Respiratory System

Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study

Pierre Thore, Jean Staentzel, Simon Valentin, Anne Guillaumot, Christine Selton-Suty, Emmanuel Gomez, Francois Chabot, Ari Chaouat

Summary: This study investigated the clinical, functional, hemodynamic characteristics, and outcomes of patients diagnosed with COPD and PH. The majority of COPD patients with PH had a pre-capillary mechanism. However, the presence of cardiovascular comorbidities and sleep apnea-hypopnea syndrome can contribute to the development of post-capillary mechanisms in some cases.

RESPIRATORY MEDICINE AND RESEARCH (2023)

Correction Public, Environmental & Occupational Health

Preventing early childhood transmission of hepatitis B in remote Aboriginal communities in northern Australia (vol 21, 186, 2022)

Richard P. Sullivan, Jane Davies, Paula Binks, Melita McKinnon, Roslyn Gundjirryiir Dhurrkay, Kelly Hosking, Sarah Mariyalawuy Bukulatjpi, Stephen Locarnini, Margaret Littlejohn, Kathy Jackson, Steven Y. C. Tong, Joshua S. Davis

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2023)

Letter Immunology

Heterogeneity in Risk of Newly Classified Typical Streptococci as Causes of Infective Endocarditis

Ouli Xie, Steven Y. C. Tong

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study

Danny Tsai, Betty B. Zam, Carleigh Tongs, Fabian Chiong, Cherian Sajiv, Basant Pawar, Aadith Ashok, Brynley P. Cooper, Steven Y. C. Tong, Sonja Janson, Steven C. Wallis, Jason A. Roberts, Suzanne L. Parker

Summary: This study described the pharmacokinetics of a 2 g three-times-weekly post-dialysis ceftriaxone regimen in Indigenous Australian patients on hemodialysis. The results showed that the recommended dosage achieved the desired unbound ceftriaxone concentrations (≥1 mg/L) for patients with serum bilirubin of 5 μmol/L. Higher bilirubin concentrations led to increased accumulation of ceftriaxone. The study also recommended against administering ceftriaxone during dialysis.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Public, Environmental & Occupational Health

The impact of rapid diagnostic testing on hospital administrative coding accuracy for influenza

Hugh C. Murray, Benjamin J. Smith, Mark Putland, Lou Irving, Douglas Johnson, Deborah A. Williamson, Steven Y. C. Tong

Summary: This study evaluated the impact of rapid PCR testing on the accuracy of hospital coding for influenza. The results showed that the introduction of rapid PCR testing was associated with more accurate coding, possibly due to faster test turnaround leading to improved clinical documentation.

INFECTION DISEASE & HEALTH (2023)

暂无数据